What are the recommendations for the management of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in patients with heart failure?
The intent of this AHA scientific statement is to summarize data relevant to contributory risk and to provide guidance on the management of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in the development and prognosis of HF to provide recommendations (Table 1) and to foster communication between physicians and other healthcare professionals and patients on the management of these comorbidities. Recommendations in this document are based on published studies and the multidisciplinary expertise of the writing group and harmonized with published practice guidelines from the American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) and other organizations.7,13 15